People channel feed

Vivek Ra­maswamy is div­ing in­to RNA, launch­ing a new biotech with Ar­bu­tus and a team of vets

8 years ago
Startups

Buck­le up: Biotech board ac­tivist Alex Den­ner is out to shake things up at Iron­wood

8 years ago

Top As­traZeneca I/O vet Robert Ian­none jumps to Im­munomedics as R&D chief as BLA looms

8 years ago
Peer Review

Jack­ie Fouse re­cruits an ex­ec­u­tive team and beefs up the der­ma­tol­ogy pipeline at Der­ma­vant

8 years ago

In sud­den re­vamp, Cel­gene CEO Alles bids his COO good­bye and looks to re­gain con­fi­dence with man­age­ment shuf­fle

8 years ago

Backed by gi­ants, an­tibi­otics up­start Macrolide gets $20M and an ex-No­var­tis ex­ec as CEO

8 years ago
Financing
Startups

In a bit­ter brawl, Arc­turus de­tails ex-CEO's al­leged mis­con­ducts in law­suit and open let­ter

8 years ago
Pharma

Rev­enue down? No wor­ries for Gilead CEO Mil­li­gan as com­pen­sa­tion swells to $15.4M

8 years ago

No­vo Nordisk's pick for new chair­man sig­nals its on­go­ing pur­suit of M&A deals

8 years ago
Deals

Shake­up at Chi­na FDA af­ter chief vaults to the helm of a reg­u­la­to­ry um­brel­la group, new agency head named

8 years ago
China

De­spite some nag­ging de­mer­its, In­cyte CEO Hervé Hop­penot still bagged $16M in com­pen­sa­tion — a 35% in­crease

8 years ago

Falling be­hind gi­ant mi­graine drug ri­vals, Alder ousts founder Randy Schatz­man — could a buy­out be next?

8 years ago

Pfiz­er per­suades CEO Ian Read to stay on for 1 more year, adding $8M bonus and bump­ing pay pack­age to $28M

8 years ago

Lousy year for share­hold­ers, but Al­ler­gan CEO Brent Saun­ders sprints past Gorsky, Gon­za­lez with $32M pay pack­age

8 years ago
R&D
Pharma

From drug­mak­er to drug man­ag­er: Ex-GSK chief An­drew Wit­ty jumps to the helm of gi­ant Op­tum

8 years ago

Gilead R&D chief Nor­bert Bischof­berg­er is leav­ing in sur­prise ex­it, CEO re­vamps top sci­ence jobs

8 years ago

Bit­ter board mem­bers at Arc­turus head to le­gal of­fice to vote on di­rec­tors

8 years ago

Op­er­a­tions head Wyss ex­its No­var­tis, giv­ing way to new struc­ture and a string of pro­mo­tions

8 years ago

Mar­tin Shkre­li sen­tenced to 7 years on felony fraud con­vic­tions

8 years ago

The un­der­dog cham­pi­on of Roche’s huge pRED group is out. John Reed is com­ing home to Amer­i­ca

8 years ago
R&D

De­flat­ing R&D claims, pros­e­cu­tors say an im­pa­tient Mar­tin Shkre­li con­duct­ed bo­gus drug study in Cyprus

8 years ago

Judg­ment day is com­ing: Fed­er­al judge or­ders Mar­tin Shkre­li to for­feit a small for­tune fol­low­ing felony con­vic­tions

8 years ago

Glob­al CRO Parex­el woos out­sourc­ing vet­er­an Jamie Mac­don­ald to the helm

8 years ago
Outsourcing

Ac­tivist in­vestor Alex Den­ner in the spot­light again as the Med­i­cines Com­pa­ny shrinks its board

8 years ago
First page Previous page 88899091929394 Next page Last page
A service from the Financial Times